BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3905750)

  • 1. Recurrent genital herpes suppressed by oral acyclovir: a multicentre double blind trial.
    Thin RN; Jeffries DJ; Taylor PK; Ayra OP; Rodin P; Yeo J; Fiddian AP
    J Antimicrob Chemother; 1985 Aug; 16(2):219-26. PubMed ID: 3905750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes.
    Mattison HR; Reichman RC; Benedetti J; Bolgiano D; Davis LG; Bailey-Farchione A; Remington M; Winter C; Corey L
    Am J Med; 1988 Aug; 85(2A):20-5. PubMed ID: 3044086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of recurrent genital herpes simplex infections with oral acyclovir.
    Ruhnek-Forsbeck M; Sandström E; Andersson B; Eriksson G; Hersle K; Lövhagen GB; Mobacken H; Hillström L; Svensson L
    J Antimicrob Chemother; 1985 Nov; 16(5):621-8. PubMed ID: 3908435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection.
    Mertz GJ; Critchlow CW; Benedetti J; Reichman RC; Dolin R; Connor J; Redfield DC; Savoia MC; Richman DD; Tyrrell DL
    JAMA; 1984 Sep; 252(9):1147-51. PubMed ID: 6088819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection.
    Douglas JM; Critchlow C; Benedetti J; Mertz GJ; Connor JD; Hintz MA; Fahnlander A; Remington M; Winter C; Corey L
    N Engl J Med; 1984 Jun; 310(24):1551-6. PubMed ID: 6328298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term oral acyclovir treatment prevents recurrent genital herpes.
    Blom I; Bäck O; Egelrud T; Frödin T; Hellbe L; Johannisson G; Malmros-Enander I; Molin L
    Dermatologica; 1986; 173(5):220-3. PubMed ID: 3100353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous acyclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial.
    Peacock JE; Kaplowitz LG; Sparling PF; Durack DT; Gnann JW; Whitley RJ; Lovett M; Bryson YJ; Klein RJ; Friedman-Kien AE
    Am J Med; 1988 Sep; 85(3):301-6. PubMed ID: 3046350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir.
    Straus SE; Takiff HE; Seidlin M; Bachrach S; Lininger L; DiGiovanna JJ; Western KA; Smith HA; Lehrman SN; Creagh-Kirk T
    N Engl J Med; 1984 Jun; 310(24):1545-50. PubMed ID: 6328297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclovir suppression of frequently recurring genital herpes. Efficacy and diminishing need during successive years of treatment.
    Straus SE; Croen KD; Sawyer MH; Freifeld AG; Felser JM; Dale JK; Smith HA; Hallahan C; Lehrman SN
    JAMA; 1988 Oct; 260(15):2227-30. PubMed ID: 2845160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral acyclovir suppressive therapy in severe recurrent genital herpes. A double-blind, placebo-controlled cross-over study.
    Kroon S; Petersen CS; Andersen LP; Rasmussen LP; Vestergaard BF
    Dan Med Bull; 1989 Jun; 36(3):298-300. PubMed ID: 2666040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic suppression for six months compared with intermittent lesional therapy of recurrent genital herpes using oral acyclovir: effects on lesions and nonlesional prodromes.
    Sacks SL; Fox R; Levendusky P; Stiver HG; Roland S; Nusinoff-Lehrman S; Keeney R
    Sex Transm Dis; 1988; 15(1):58-62. PubMed ID: 3282336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic oral acyclovir in recurrent genital herpes.
    Mindel A; Weller IV; Faherty A; Sutherland S; Hindley D; Fiddian AP; Adler MW
    Lancet; 1984 Jul; 2(8394):57-9. PubMed ID: 6146006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of recurrent genital herpes by single daily dosages of acyclovir.
    Mostow SR; Mayfield JL; Marr JJ; Drucker JL
    Am J Med; 1988 Aug; 85(2A):30-3. PubMed ID: 3044089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year suppression of frequent recurrences of genital herpes with oral acyclovir.
    Baker DA; Blythe JG; Kaufman R; Hale R; Portnoy J
    Obstet Gynecol; 1989 Jan; 73(1):84-7. PubMed ID: 2642329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial.
    Mertz GJ; Jones CC; Mills J; Fife KH; Lemon SM; Stapleton JT; Hill EL; Davis LG
    JAMA; 1988 Jul; 260(2):201-6. PubMed ID: 3290517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects.
    Bryson YJ; Dillon M; Lovett M; Acuna G; Taylor S; Cherry JD; Johnson BL; Wiesmeier E; Growdon W; Creagh-Kirk T; Keeney R
    N Engl J Med; 1983 Apr; 308(16):916-21. PubMed ID: 6339923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, placebo-controlled trial of the effect of chronically administered oral acyclovir on sperm production in men with frequently recurrent genital herpes.
    Douglas JM; Davis LG; Remington ML; Paulsen CA; Perrin EB; Goodman P; Conner JD; King D; Corey L
    J Infect Dis; 1988 Mar; 157(3):588-93. PubMed ID: 2830348
    [No Abstract]   [Full Text] [Related]  

  • 18. Genital herpes: oral treatment with acyclovir.
    Ruhnek-Forsbeck M
    Scand J Infect Dis Suppl; 1985; 47():63-6. PubMed ID: 3912973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes.
    Mindel A; Faherty A; Carney O; Patou G; Freris M; Williams P
    Lancet; 1988 Apr; 1(8591):926-8. PubMed ID: 2895840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial.
    Reichman RC; Badger GJ; Mertz GJ; Corey L; Richman DD; Connor JD; Redfield D; Savoia MC; Oxman MN; Bryson Y
    JAMA; 1984 Apr; 251(16):2103-7. PubMed ID: 6368877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.